Claims that need an answer
Know when to pause.
Pause when the basic checks remain unanswered. A lower price or a polished page does not supply the missing clinician, pharmacy or product explanation.
Question to carry
Pause at a prescription-medicine offer that skips a prescription.
Read the offer
No prescription or an untrue approval claim
As of September 2026, supplying prescription medicine without a valid prescription breaches federal law. The federal prescription rule
As of September 2026, FDA describes claims of its approval for compounded medicines as false or misleading. FDA’s guidance on approval claims
Ask for an explanation in writing. If the answer repeats the claim instead of naming the medicine and the person who would prescribe it, pause. Do not pay until you have those answers.
Look more closely
“For research use only” alongside treatment claims
Look for the words “for research use only” on a research label. Another wording is “not for human consumption”. It describes a product meant for studies, not for people to use as treatment.
FDA’s position, checked in September 2026, is that research-labeled weight-drug products marketed for human use have unknown quality and may be harmful. FDA on research-labeled products
As of September 2026, FDA’s position is that federal law forbids compounding retatrutide or cagrilintide. FDA on these proposed treatments
Keep the exact name in your notes. Ask a clinician about care for your concern rather than treating a research label as a route to care.
Look more closely
Nobody available after the medicine arrives
FDA’s checklist, checked in September 2026, warns about telehealth offers that leave patients without a licensed doctor to answer questions after they receive medicine. FDA’s consumer checklist
Ask who answers questions about the treatment or how you feel after taking it. Read the answer before paying. A contact form alone does not explain who would handle your concern.
Carry this forward
A severe reaction needs urgent help
In MedlinePlus guidance checked in September 2026, difficulty breathing and a swollen face or tongue are signs of a severe allergic reaction. The US health guide on severe allergic reactions
That guidance calls for emergency care when symptoms are severe. Read the emergency-care guidance
A billing question can wait. A severe reaction calls for urgent care rather than waiting for a routine message reply.
Keep in mind
The chapter recap
Pause over a missing prescription, a false approval claim, a treatment labeled “for research use only” or nobody to answer treatment questions later.
Plan the follow-up